Abiraterone Acetate Tablet
Product Images NDC 43598-358

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 43598-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Label for Abiraterone Acetate Tablets, USP 250 mg by Dr. Reddys Laboratories Inc. The label states the dosage strength (250 mg), dosage form (tablet), and count (120 tablets). It includes key storage instructions, usage warnings about handling for pregnant women, and the NDC number 43598-358-04. Manufacturer and distributor information, along with a barcode, are also visible.*

FDA Label Image

Figure1 (Figure1)

A survival curve graph comparing % survival over time to death in months for Abiraterone Acetate versus placebo. The graph includes sample size counts at various time points, illustrating differences in survival rates between the two groups over an 18-month period.*

FDA Label Image

Figure2 (Figure2)

A survival curve chart depicting the percentage of subjects without death over months from randomization for Abiraterone Acetate compared to placebo. The x-axis shows months from randomization up to approximately 57 months; the y-axis shows the percentage of subjects without death from 0 to 100%. Two lines represent the survival trends for Abiraterone Acetate and placebo groups.*

FDA Label Image

Figure3 (Figure3)

A Kaplan-Meier survival curve comparing the percentage of subjects without radiographic progression or death over months from randomization between Abiraterone Acetate and placebo groups. The graph displays a higher survival percentage in the Abiraterone Acetate group across the study duration up to 18 months.*

FDA Label Image

Figure4

A survival curve graph comparing the percentage of subjects without death over time between Abiraterone Acetate and Placebo groups. The X-axis shows months from randomization up to 66 months, and the Y-axis represents the percentage survival. The graph includes a legend and a table of subjects at risk for each group at different time points.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Abiraterone Acetate, illustrating its steroidal backbone and functional groups, including a pyridine ring and an acetate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.